Calidi Biotherapeutics, Inc. also files under FLAG; those filings are included.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 17, 2026 | Sanders Corazon (Corsee) D. | Director | Grant(A) | 6K | — | $0 |
| Aug 17, 2026 | Peoples George | Director | Grant(A) | 4K | — | $0 |
| Aug 17, 2026 | Leftwich Scott | Director | Grant(A) | 4K | — | $0 |
| Aug 17, 2026 | Schoeneck James A | Director | Grant(A) | 5K | — | $0 |
| Aug 17, 2026 | Stewart Alan R. | Director | Grant(A) | 4K | — | $0 |
| Aug 17, 2026 | Jackson Andrew C. | Chief Financial Officer | Grant(A) | 14K | — | — |
| Aug 17, 2026 | Poma Eric E | Chief Executive Officer | Grant(A) | 32K | — | — |
| Aug 17, 2026 | Fernandez Santidrian Antonio | Chief Scientific Officer | Grant(A) | 16K | — | — |
| Dec 12, 2025 | Camaisa Allan | Director | Sell(S) | 850 | $1.46 | $1K |
| Sep 3, 2025 | Fernandez Santidrian Antonio | Chief Scientific Officer | Grant(A) | 35K | — | — |
| Sep 3, 2025 | Jackson Andrew C. | Chief Financial Officer | Grant(A) | 30K | — | — |
| Sep 3, 2025 | Poma Eric E | Chief Executive Officer | Grant(A) | 10K | — | — |
| Aug 21, 2025 | Schoeneck James A | Director | Buy(P) | 75K | — | — |
| Aug 21, 2025 | Jackson Andrew C. | Chief Financial Officer | Buy(P) | 3K | $2.00 | $5K |
| Aug 21, 2025 | Jackson Andrew C. | Chief Financial Officer | Buy(P) | 3K | — | — |
| Aug 21, 2025 | Leftwich Scott | Director | Buy(P) | 125K | — | — |
| Aug 21, 2025 | Leftwich Scott | Director | Buy(P) | 125K | $2.00 | $250K |
| Aug 21, 2025 | Poma Eric E | Chief Executive Officer, Director | Buy(P) | 25K | $2.00 | $50K |
| Aug 21, 2025 | Poma Eric E | Chief Executive Officer, Director | Buy(P) | 25K | — | — |
| Aug 21, 2025 | Schoeneck James A | Director | Buy(P) | 75K | $2.00 | $150K |
| Jul 9, 2025 | Leftwich Scott | Director | Grant(A) | 137K | — | $0 |
| Jul 9, 2025 | Peoples George | Director | Grant(A) | 137K | — | $0 |
| Jul 9, 2025 | Schoeneck James A | Director | Grant(A) | 164K | — | $0 |
| Jul 9, 2025 | Stewart Alan R. | Director | Grant(A) | 137K | — | $0 |
| Apr 22, 2025 | Poma Eric E | Chief Executive Officer, Director | Grant(A) | 726K | — | — |
| Dec 31, 2024 | Leftwich Scott | Director | Grant(A) | 12K | — | — |
| Dec 31, 2024 | Stewart Alan R. | Director | Grant(A) | 13K | — | — |
| Dec 17, 2024 | Camaisa Allan | CEO and Chairman of the Board, Director | Sell(S) | 10K | $1.62 | $16K |
| Sep 26, 2024 | Camaisa Allan | CEO and Chairman of the Board, Director, 10% Owner | Grant(A) | 70K | $1.15 | $81K |
| Sep 20, 2024 | Peoples George | Director | Grant(A) | 20K | — | — |
| Sep 20, 2024 | Stewart Alan R. | Director | Grant(A) | 20K | — | — |
| Sep 20, 2024 | Schoeneck James A | Director | Grant(A) | 20K | — | — |
| Sep 20, 2024 | Leftwich Scott | Director | Grant(A) | 20K | — | — |
| Jul 1, 2024 | Peoples George | Director | Grant(A) | 31K | — | — |
| Jun 28, 2024 | Schoeneck James A | Director | Grant(A) | 80K | — | — |
| Jun 28, 2024 | Leftwich Scott | Director | Grant(A) | 67K | — | — |
| Jun 28, 2024 | Stewart Alan R. | Director | Grant(A) | 73K | — | — |
| Jun 17, 2024 | Campbell Wendy Pizarro | Chief Admin. and Legal Officer | Grant(A) | 40K | — | — |
| Jun 17, 2024 | Camaisa Allan | CEO and Chairman of the Board, Director, 10% Owner | Grant(A) | 40K | — | — |
| Jun 17, 2024 | Campbell Wendy Pizarro | Chief Admin. and Legal Officer | Grant(A) | 60K | — | — |
| Jun 17, 2024 | Jackson Andrew C. | Chief Financial Officer | Grant(A) | 300K | — | — |
| Jun 17, 2024 | Minev Boris Radoslavov | Interim Chief Medical Officer | Grant(A) | 31K | — | — |
| Jun 3, 2024 | Schoeneck James A | Director | Option exercise(M) | 173K | — | — |
| Jun 3, 2024 | Schoeneck James A | Director | Option exercise(M) | 375K | $0.20 | $75K |
| Jun 3, 2024 | Schoeneck James A | Director | Option exercise(M) | 173K | $0.20 | $35K |
| Jun 3, 2024 | Schoeneck James A | Director | Option exercise(M) | 173K | — | — |
| Jun 3, 2024 | Schoeneck James A | Director | Option exercise(M) | 375K | — | — |
| Jun 3, 2024 | Schoeneck James A | Director | Grant(A) | 548K | — | — |
| Jun 3, 2024 | Schoeneck James A | Director | Option exercise(M) | 375K | — | — |
| Apr 18, 2024 | Schoeneck James A | Director | Grant(A) | 375K | $0.40 | $150K |
| Apr 18, 2024 | Schoeneck James A | Director | Grant(A) | 375K | — | — |
| Apr 18, 2024 | Schoeneck James A | Director | Grant(A) | 375K | — | — |
| Apr 18, 2024 | Schoeneck James A | Director | Grant(A) | 375K | — | — |
| Mar 29, 2024 | Schoeneck James A | Director | Grant(A) | 28K | — | — |
| Mar 29, 2024 | Leftwich Scott | Director | Grant(A) | 24K | — | — |
| Mar 29, 2024 | Stewart Alan R. | Director | Grant(A) | 26K | — | — |
| Dec 21, 2023 | Leftwich Scott | Director | Grant(A) | 9K | $1.80 | $16K |
| Dec 21, 2023 | Leftwich Scott | Director | Grant(A) | 70K | — | — |
| Dec 21, 2023 | Schoeneck James A | Director | Grant(A) | 11K | $1.80 | $19K |
| Dec 21, 2023 | Schoeneck James A | Director | Grant(A) | 70K | — | — |
| Dec 21, 2023 | Stewart Alan R. | Director | Grant(A) | 7K | $1.80 | $13K |
| Dec 21, 2023 | Zulueta Alfonso G | Director | Grant(A) | 6K | $1.80 | $10K |
| Dec 21, 2023 | Vecchiolla Thomas A. | Director | Grant(A) | 8K | $1.80 | $14K |
| Dec 21, 2023 | Camaisa Allan | CEO, President and Chairman, Director, 10% Owner | Grant(A) | 100K | — | — |
| Sep 12, 2023 | FLAG Sponsor Manager, LLC | 10% Owner | Sell(S) | 99K | — | — |
| Sep 12, 2023 | FLAG Sponsor Manager, LLC | 10% Owner | Other(J) | 166K | — | — |
| Sep 12, 2023 | Hudson Bay Capital Management LP | 10% Owner | Other(J) | 500K | $10.49 | $5.2M |
| Sep 12, 2023 | FLAG Sponsor Manager, LLC | 10% Owner | Conversion(C) | 1.9M | — | — |
| Sep 12, 2023 | Vecchiolla Thomas A. | Director | Other(J) | 67K | — | — |
| Sep 12, 2023 | Vecchiolla Thomas A. | Director | Other(J) | 6K | — | — |
| Sep 12, 2023 | Vecchiolla Thomas A. | Director | Conversion(C) | 6K | — | — |
| Sep 12, 2023 | Vecchiolla Thomas A. | Director | Conversion(C) | 6K | — | — |
| Sep 12, 2023 | FLAG Sponsor Manager, LLC | 10% Owner | Sell(S) | 186K | — | — |
| Sep 12, 2023 | FLAG Sponsor Manager, LLC | 10% Owner | Conversion(C) | 1.9M | — | — |
| Jun 16, 2023 | FLAG Sponsor Manager, LLC | 10% Owner | Sell(S) | 192K | — | — |
| Oct 19, 2022 | Polar Asset Management Partners Inc. | 10% Owner | Sell(S) | 36K | $9.90 | $358K |
| Sep 13, 2022 | First Light Acquisition Group, LLC | Chief Executive Officer, Director, 10% Owner | Sell(S) | 400K | $0.10 | $40K |
| Sep 12, 2022 | First Light Acquisition Group, LLC | Chief Executive Officer, Director, 10% Owner | Sell(S) | 450K | $1.00 | $450K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Calidi Biotherapeutics, Inc., SEC CIK 0001855485. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under CLDI and shows every filing by that issuer (also filed as FLAG).
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-12. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for CLDI